Related Experiment Video
Updated: May 4, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
NCOA5, IL-6, type 2 diabetes, and HCC: The deadly quartet
Debanjan Dhar1, Ekihiro Seki2, Michael Karin3
1Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, University of California, San Diego, School of Medicine, 9500 Gilman Drive, San Diego, CA 92093, USA.
Abstract:
Although type 2 diabetes (T2D) is an established risk factor for hepatocellular carcinoma (HCC), the underlying mechanism that connects these two diseases is unknown. Gao et al. (2013) now suggest that nuclear receptor coactivator 5 (NCOA5) provides a genetic link between the two diseases through its effects on hepatic IL-6 expression.
More Related Videos
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Psychoneuroimmunology: Diabetes and Cancer
Type I Diabetes I: Introduction
Chronic Pancreatitis II: Pathophysiology

